Experimental cancer drug study halted early

NCT ID NCT04106492

Terminated Disease control Sponsor: Shasqi, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 16, 2025 · Last updated May 08, 2026 · Updated 22 times

Summary

This study tested an experimental drug called SQ3370 in 53 people with advanced solid tumors that had stopped responding to other treatments. The main goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Cancer Research Institute

Adelaide, South Australia, 5000, Australia
Chris O'Brien Lifehouse

Camperdown, New South Wales, 2050, Australia
City of Hope

Duarte, California, 91010, United States
MD Anderson Cancer Center

Houston, Texas, 77030, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
Royal North Shore Hospital

Sydney, New South Wales, 2065, Australia
Sarcoma Oncology Center

Santa Monica, California, 90403, United States
Stanford Cancer Center

Palo Alto, California, 94304, United States
University of Washington

Seattle, Washington, 98195, United States
Washington University in St. Louis

St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.

CANCER